Navigation Links
Cardica Receives NASDAQ Notification
Date:5/22/2009

REDWOOD CITY, Calif., May 22 /PRNewswire-FirstCall/ -- Cardica, Inc. (Nasdaq: CRDC) today announced that, on May 19, 2009, it received a notice from the Listing Qualifications Department of The NASDAQ Global Market (NASDAQ) that the Company does not comply with the minimum $10 million stockholders' equity requirement for continued listing on the NASDAQ Global Market as stated under NASDAQ Marketplace Rule 5450(b)(1)(A) (the "Minimum Equity Requirement").

As provided by NASDAQ rules, Cardica has the opportunity to submit to NASDAQ on or before June 3, 2009, a specific plan and timeline to regain and sustain compliance with the Minimum Equity requirement. There is no assurance that NASDAQ will accept the Company's plan to satisfy the stockholders' equity requirement. If NASDAQ accepts Cardica's plan, NASDAQ may grant Cardica a period of up to 105 days from May 19, 2009 to regain compliance with such listing requirements. If NASDAQ determines that Cardica's plan is not sufficient to achieve and sustain compliance with the Minimum Equity Requirement, NASDAQ will provide written notice that Cardica's securities will be subject to delisting from the NASDAQ Global Market. At such time, Cardica may then apply to move to The NASDAQ Capital Market, provided it meets the continued listing requirements of that market, or appeal NASDAQ's delisting determination to a NASDAQ Listing Qualifications Panel. In the event of an appeal, Cardica's securities would remain listed on The NASDAQ Global Market pending a decision by the Panel following the hearing.

About Cardica

Cardica is a leading provider of automated anastomosis systems for coronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutures with easy-to-use automated systems, Cardica's products provide cardiovascular surgeons with rapid, reliable and consistently reproducible anastomoses, or connections of blood vessels, often considered the most critical aspect of the CABG procedure. Cardica's C-Port(R) Distal Anastomosis Systems are marketed in the United States and Europe and its PAS-Port(R) Proximal Anastomosis System is marketed in the United States, Europe and Japan.

Forward-Looking Statements

This press release contains "forward-looking statements," including, without limitation, statements related to Cardica's plan to submit a compliance plan to NASDAQ, the continued listing of Cardica's common stock on The NASDAQ Global Market and potential outcomes following that submission. The words "may," "intends" and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause Cardica's results to differ materially from those indicated by these forward-looking statements, including, without limitation, the risk that the NASDAQ Staff may reject the Company's plan for meeting the minimum continued listing requirements and the risk that Cardica otherwise fails to comply with the continued listing requirements of The NASDAQ Global Market or any other NASDAQ market, as well as other risks detailed from time to time in Cardica's SEC reports, including its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2009. Cardica expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. You are encouraged to read Cardica's reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov.


'/>"/>
SOURCE Cardica, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cardica to Announce Fiscal 2009 Third Quarter Financial Results on Monday, May 4, 2009
2. Cardica to Announce Fiscal 2009 Second Quarter Financial Results on Thursday, January 29, 2009
3. Cardica Announces Publication of Case Report in the Journal of Neurosurgery Featuring Use of C-Port(R) System in Brain Arterial Bypass
4. Cardica to Present at William Blair Small-Cap Growth Stock Conference
5. Cardica to Host Conference Call at 11:00 a.m. Eastern Time Tomorrow to Provide Positive Update on Pas-Port(R)
6. Cardica to Announce Fiscal 2008 Fourth Quarter and Year End Financial Results on Tuesday, August 5, 2008
7. Cardica Names Frederick Bauer Vice President of Operations
8. Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C-Port(R) Flex-A(R) Anastomosis System in His Practice and to Educate Cardiothoracic Surgeons
9. Cardica, Intuitive Surgical, MAQUET Cardiovascular and Transonic to Host Innovations in Revascularization Symposium
10. Cardica to Announce Fiscal 2008 Third Quarter Financial Results on Tuesday, April 29, 2008
11. Cardicas C-Port Anastomosis Systems Facilitate Beating Heart Bypass Surgery in Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... , ... Goodcents Deli Fresh Subs today announced the opening of a new ... St. Topeka, Kan. 66604 (near 21st and Gage). It is owned and operated by ... locations in the Topeka and Bonner Springs, Kan. area. , “Goodcents has such ...
(Date:6/23/2017)... ... June 23, 2017 , ... 21 Middle East and ... has selected 21 leaders from government, business and civil society in 11 countries across ... U.S. this fall, engaging in a transformative exchange of knowledge and ideas with the ...
(Date:6/23/2017)... ... , ... American Farmer, will feature Chr. Hansen, Inc (CHR Hansen) in an ... 2017. American Farmer airs Tuesdays at 8:30aET on RFD-TV. Check your local listings for ... Denmark in 1874 after a groundbreaking discovery of how to industrialize enzymes. Rooted in ...
(Date:6/23/2017)... TX (PRWEB) , ... June 23, 2017 , ... All-Star ... to residential and business clients throughout eastern Texas, is announcing the launch of a ... , Recent breast cancer statistics in the United States reveal that an estimated 252, ...
(Date:6/22/2017)... ... 22, 2017 , ... Plastic Surgery Associates is proud to report that founding ... year, research and information firm, Castle Connolly, releases their list of the most notable ... the 3rd time that Dr. Canales has been recognized by Castle Connolly. ...
Breaking Medicine News(10 mins):
(Date:6/19/2017)... , June 19, 2017  Researchers from DRUGSCAN ... that they will host a live, complimentary webinar titled, ... the benchtop to the real world" on Wednesday June ... This webinar will feature interviews with ... look into the manipulation techniques abusers use to prepare ...
(Date:6/14/2017)... June 14, 2017 The Bio Supply Management ... City of Fremont and the Biomedical Manufacturing ... industry in California by providing ... networking, and fostering workforce development. The primary focus of ... of start-ups, as well as small and mid-sized biomedical ...
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
Breaking Medicine Technology: